銵?鋆蔭?詨
ABOUT US PIPELINE
LBS-008
LBS-009
LBS-007
LBS-002
MEDIA & PUBLICATION
NEWS
PUBLICATION
INVESTORS
Events & Presentation
Investor Conference
Financial Information
Corporate Governance
CONTACT US
MEDIA & PUBLICATION
HOMEMEDIA & PUBLICATIONNEWS
NEWS
PUBLICATION
NEWS
Lin BioScience Licenses a Novel Anti-Cancer Therapy for Hematological Malignancies and Solid Tumors from Columbia University and Memorial Sloan Kettering Cancer Center
Mar 03 , 2017
Lin Bioscience Licenses First-in-Class Therapeutic Program to treat Dry Aged-Related Macular Degeneration from Columbia University in Collaboration with NIH
Jan 06 , 2017